Mayme Lou Roettig, RN, MSN

Mayme Lou Roettig was appointed Senior Vice President of the Baim Institute for Clinical Research in August 2023, after serving as a strategic consultant for the Institute and Dr. Gibson beginning in December 2022. In her role, she oversees strategic initiatives, supports the CEO and faculty in new business activities, and drives the development of research and education programs. She has collaborated with Dr. Gibson for more than 30 years in education, clinical development, and outcomes research.

Ms. Roettig is a cardiovascular clinical nurse specialist whose career has centered on advancing evidence-based research into practice to improve patient outcomes. She has held clinical positions in coronary and critical care units, medical telemetry units, and interventional cardiac catheterization labs, as well as serving as an advanced practice nurse in cardiology clinics. Her research career spans early-phase to large phase 3 clinical trials, with a particular focus on outcomes research, quality initiatives, and implementation science.

Prior to joining Baim, Ms. Roettig held leadership roles within Genentech’s Cardiovascular franchise (1996–2004) during the fibrinolysis era for myocardial infarction and acute ischemic stroke. She was a pioneer in early U.S. quality improvement and systems-of-care initiatives for ST-Elevation Myocardial Infarction (STEMI), helping to transform how the healthcare system responds to patients experiencing acute coronary syndromes.

From 2005 to 2019, Ms. Roettig worked at the Duke Clinical Research Institute, Duke University, in multiple leadership roles, including Executive Director of the RACE Campaigns in STEMI and Cardiac Arrest, Assistant Director for the Center of Educational Excellence, and Operations Director of Health Systems and Implementation Science in Health Services Research. In these roles, she contributed to major studies such as Accelerator, IMPACT AF, IMPROVE Stroke Care, and COORDINATE Diabetes.

In addition, she served as National Director of the American Heart Association’s flagship Mission Lifeline STEMI Initiative (2008–2010), working with volunteer leadership to improve emergency response systems for heart attack patients nationwide.